(A, B) Comparisons of the daf-2(e1370), daf-16(mu86), and daf-2(e1370);daf-16(mu86) mutant animals to wild-type N2 animals in 40 µg/ml purified Cry5B or 8 µg/ml Cry21A indicate daf-2(e1370) mutant and daf-2(e1370);daf-16(mu86) double mutant are all statistically resistant to Cry5B and Cry21A compared with N2. * indicates P<0.001 (P<0.05 in B) relative to wild-type N2. # indicates P<0.001 (P<0.05 in B) relative to daf-2(e1370);daf-16(mu86) mutant. (C) Comparisons of the mutants in the canonical DAF-2 insulin-like signaling pathway, including daf-2(e1370), age-1(hx546), aap-1(m889), daf-18(e1375), pdk-1(sa680), pdk-1(sa709), akt-1(sa573), akt-1(ok525), akt-1(mg144), akt-2(ok393), sgk-1(ok538), daf-16(mu86), daf-2(e1370);daf-16(mu86), to wild-type N2 animals in E. coli-expressed Cry5B liquid toxicity assay. * indicates P<0.01 relative to wild-type N2. (D, E) Dose-dependent mortality were performed using purified Cry5B toxin to quantitatively compare sensitivities of wild-type N2 to the daf-2(e1370), pdk-1(sa680), pdk-1(sa709), pdk-1(mg142), akt-1(ok525), akt-1(sa573), akt-2(ok393), and sgk-1(ok538) mutants. This semi-log graph represents three independent experiments, and each data point shows the mean and standard deviations from three experiments.